Ryan W Logan1, Nicole Edgar1, Andrea G Gillman1, Daniel Hoffman1, Xiyu Zhu1, Colleen A McClung2. 1. Department of Psychiatry and Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania. 2. Department of Psychiatry and Translational Neuroscience Program, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.. Electronic address: mcclungca@upmc.edu.
Abstract
BACKGROUND: Emerging evidence implicates circadian abnormalities as a component of the pathophysiology of major depressive disorder (MDD). The suprachiasmatic nucleus (SCN) of the hypothalamus coordinates rhythms throughout the brain and body. On a cellular level, rhythms are generated by transcriptional, translational, and posttranslational feedback loops of core circadian genes and proteins. In patients with MDD, recent evidence suggests reduced amplitude of molecular rhythms in extra-SCN brain regions. We investigated whether unpredictable chronic mild stress (UCMS), an animal model that induces a depression-like physiological and behavioral phenotype, induces circadian disruptions similar to those seen with MDD. METHODS: Activity and temperature rhythms were recorded in C57BL/6J mice before, during, and after exposure to UCMS, and brain tissue explants were collected from Period2 luciferase mice following UCMS to assess cellular rhythmicity. RESULTS: UCMS significantly decreased circadian amplitude of activity and body temperature in mice, similar to findings in MDD patients, and these changes directly correlated with depression-related behavior. While amplitude of molecular rhythms in the SCN was decreased following UCMS, surprisingly, rhythms in the nucleus accumbens (NAc) were amplified with no changes seen in the prefrontal cortex or amygdala. These molecular rhythm changes in the SCN and the NAc also directly correlated with mood-related behavior. CONCLUSIONS: These studies found that circadian rhythm abnormalities directly correlate with depression-related behavior following UCMS and suggest a desynchronization of rhythms in the brain with an independent enhancement of rhythms in the NAc.
BACKGROUND: Emerging evidence implicates circadian abnormalities as a component of the pathophysiology of major depressive disorder (MDD). The suprachiasmatic nucleus (SCN) of the hypothalamus coordinates rhythms throughout the brain and body. On a cellular level, rhythms are generated by transcriptional, translational, and posttranslational feedback loops of core circadian genes and proteins. In patients with MDD, recent evidence suggests reduced amplitude of molecular rhythms in extra-SCN brain regions. We investigated whether unpredictable chronic mild stress (UCMS), an animal model that induces a depression-like physiological and behavioral phenotype, induces circadian disruptions similar to those seen with MDD. METHODS: Activity and temperature rhythms were recorded in C57BL/6J mice before, during, and after exposure to UCMS, and brain tissue explants were collected from Period2 luciferase mice following UCMS to assess cellular rhythmicity. RESULTS: UCMS significantly decreased circadian amplitude of activity and body temperature in mice, similar to findings in MDDpatients, and these changes directly correlated with depression-related behavior. While amplitude of molecular rhythms in the SCN was decreased following UCMS, surprisingly, rhythms in the nucleus accumbens (NAc) were amplified with no changes seen in the prefrontal cortex or amygdala. These molecular rhythm changes in the SCN and the NAc also directly correlated with mood-related behavior. CONCLUSIONS: These studies found that circadian rhythm abnormalities directly correlate with depression-related behavior following UCMS and suggest a desynchronization of rhythms in the brain with an independent enhancement of rhythms in the NAc.
Authors: Alex Y -L So; Teresita U Bernal; Marlisa L Pillsbury; Keith R Yamamoto; Brian J Feldman Journal: Proc Natl Acad Sci U S A Date: 2009-10-05 Impact factor: 11.205
Authors: Jacques Barik; Sébastien Parnaudeau; Aurélie Lampin Saint Amaux; Bruno P Guiard; Jose Felipe Golib Dzib; Olivier Bocquet; Alain Bailly; Arndt Benecke; François Tronche Journal: Biol Psychiatry Date: 2010-06-15 Impact factor: 13.382
Authors: E Souêtre; E Salvati; J L Belugou; D Pringuey; M Candito; B Krebs; J L Ardisson; G Darcourt Journal: Psychiatry Res Date: 1989-06 Impact factor: 3.222
Authors: Jodi R Paul; Jennifer A Davis; Lacy K Goode; Bryan K Becker; Allison Fusilier; Aidan Meador-Woodruff; Karen L Gamble Journal: Eur J Neurosci Date: 2019-01-29 Impact factor: 3.386
Authors: Sydney Aten; Yixing Du; Olivia Taylor; Courtney Dye; Kelsey Collins; Matthew Thomas; Conrad Kiyoshi; Min Zhou Journal: Neurochem Res Date: 2022-07-07 Impact factor: 4.414
Authors: Alessandra Porcu; Megan Vaughan; Anna Nilsson; Natsuko Arimoto; Katja Lamia; David K Welsh Journal: Proc Natl Acad Sci U S A Date: 2020-06-02 Impact factor: 11.205